Cargando…
Involvement of mTOR pathway in neurodegeneration in NSF-related developmental and epileptic encephalopathy
Membrane fusion is mediated by soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins. During neurotransmitter exocytosis, SNARE proteins on a synaptic vesicle and the target membrane form a complex, resulting in neurotransmitter release. N-ethylmaleimide-sensitive fa...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162430/ https://www.ncbi.nlm.nih.gov/pubmed/36645181 http://dx.doi.org/10.1093/hmg/ddad008 |
_version_ | 1785037698279407616 |
---|---|
author | Hayashi, Takahiro Yano, Naoko Kora, Kengo Yokoyama, Atsushi Maizuru, Kanako Kayaki, Taisei Nishikawa, Kinuko Osawa, Mitsujiro Niwa, Akira Takenouchi, Toshiki Hijikata, Atsushi Shirai, Tsuyoshi Suzuki, Hisato Kosaki, Kenjiro Saito, Megumu K Takita, Junko Yoshida, Takeshi |
author_facet | Hayashi, Takahiro Yano, Naoko Kora, Kengo Yokoyama, Atsushi Maizuru, Kanako Kayaki, Taisei Nishikawa, Kinuko Osawa, Mitsujiro Niwa, Akira Takenouchi, Toshiki Hijikata, Atsushi Shirai, Tsuyoshi Suzuki, Hisato Kosaki, Kenjiro Saito, Megumu K Takita, Junko Yoshida, Takeshi |
author_sort | Hayashi, Takahiro |
collection | PubMed |
description | Membrane fusion is mediated by soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins. During neurotransmitter exocytosis, SNARE proteins on a synaptic vesicle and the target membrane form a complex, resulting in neurotransmitter release. N-ethylmaleimide-sensitive factor (NSF), a homohexameric ATPase, disassembles the complex, allowing individual SNARE proteins to be recycled. Recently, the association between pathogenic NSF variants and developmental and epileptic encephalopathy (DEE) was reported; however, the molecular pathomechanism of NSF-related DEE remains unclear. Here, three patients with de novo heterozygous NSF variants were presented, of which two were associated with DEE and one with a very mild phenotype. One of the DEE patients also had hypocalcemia from parathyroid hormone deficiency and neuromuscular junction impairment. Using PC12 cells, a neurosecretion model, we show that NSF with DEE-associated variants impaired the recycling of vesicular membrane proteins and vesicle enlargement in response to exocytotic stimulation. In addition, DEE-associated variants caused neurodegenerative change and defective autophagy through overactivation of the mammalian/mechanistic target of rapamycin (mTOR) pathway. Treatment with rapamycin, an mTOR inhibitor or overexpression of wild-type NSF ameliorated these phenotypes. Furthermore, neurons differentiated from patient-derived induced pluripotent stem cells showed neurite degeneration, which was also alleviated by rapamycin treatment or gene correction using genome editing. Protein structure analysis of NSF revealed that DEE-associated variants might disrupt the transmission of the conformational change of NSF monomers and consequently halt the rotation of ATP hydrolysis, indicating a dominant negative mechanism. In conclusion, this study elucidates the pathomechanism underlying NSF-related DEE and identifies a potential therapeutic approach. |
format | Online Article Text |
id | pubmed-10162430 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-101624302023-05-06 Involvement of mTOR pathway in neurodegeneration in NSF-related developmental and epileptic encephalopathy Hayashi, Takahiro Yano, Naoko Kora, Kengo Yokoyama, Atsushi Maizuru, Kanako Kayaki, Taisei Nishikawa, Kinuko Osawa, Mitsujiro Niwa, Akira Takenouchi, Toshiki Hijikata, Atsushi Shirai, Tsuyoshi Suzuki, Hisato Kosaki, Kenjiro Saito, Megumu K Takita, Junko Yoshida, Takeshi Hum Mol Genet Original Article Membrane fusion is mediated by soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins. During neurotransmitter exocytosis, SNARE proteins on a synaptic vesicle and the target membrane form a complex, resulting in neurotransmitter release. N-ethylmaleimide-sensitive factor (NSF), a homohexameric ATPase, disassembles the complex, allowing individual SNARE proteins to be recycled. Recently, the association between pathogenic NSF variants and developmental and epileptic encephalopathy (DEE) was reported; however, the molecular pathomechanism of NSF-related DEE remains unclear. Here, three patients with de novo heterozygous NSF variants were presented, of which two were associated with DEE and one with a very mild phenotype. One of the DEE patients also had hypocalcemia from parathyroid hormone deficiency and neuromuscular junction impairment. Using PC12 cells, a neurosecretion model, we show that NSF with DEE-associated variants impaired the recycling of vesicular membrane proteins and vesicle enlargement in response to exocytotic stimulation. In addition, DEE-associated variants caused neurodegenerative change and defective autophagy through overactivation of the mammalian/mechanistic target of rapamycin (mTOR) pathway. Treatment with rapamycin, an mTOR inhibitor or overexpression of wild-type NSF ameliorated these phenotypes. Furthermore, neurons differentiated from patient-derived induced pluripotent stem cells showed neurite degeneration, which was also alleviated by rapamycin treatment or gene correction using genome editing. Protein structure analysis of NSF revealed that DEE-associated variants might disrupt the transmission of the conformational change of NSF monomers and consequently halt the rotation of ATP hydrolysis, indicating a dominant negative mechanism. In conclusion, this study elucidates the pathomechanism underlying NSF-related DEE and identifies a potential therapeutic approach. Oxford University Press 2023-01-16 /pmc/articles/PMC10162430/ /pubmed/36645181 http://dx.doi.org/10.1093/hmg/ddad008 Text en © The Author(s) 2023. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Hayashi, Takahiro Yano, Naoko Kora, Kengo Yokoyama, Atsushi Maizuru, Kanako Kayaki, Taisei Nishikawa, Kinuko Osawa, Mitsujiro Niwa, Akira Takenouchi, Toshiki Hijikata, Atsushi Shirai, Tsuyoshi Suzuki, Hisato Kosaki, Kenjiro Saito, Megumu K Takita, Junko Yoshida, Takeshi Involvement of mTOR pathway in neurodegeneration in NSF-related developmental and epileptic encephalopathy |
title | Involvement of mTOR pathway in neurodegeneration in NSF-related developmental and epileptic encephalopathy |
title_full | Involvement of mTOR pathway in neurodegeneration in NSF-related developmental and epileptic encephalopathy |
title_fullStr | Involvement of mTOR pathway in neurodegeneration in NSF-related developmental and epileptic encephalopathy |
title_full_unstemmed | Involvement of mTOR pathway in neurodegeneration in NSF-related developmental and epileptic encephalopathy |
title_short | Involvement of mTOR pathway in neurodegeneration in NSF-related developmental and epileptic encephalopathy |
title_sort | involvement of mtor pathway in neurodegeneration in nsf-related developmental and epileptic encephalopathy |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162430/ https://www.ncbi.nlm.nih.gov/pubmed/36645181 http://dx.doi.org/10.1093/hmg/ddad008 |
work_keys_str_mv | AT hayashitakahiro involvementofmtorpathwayinneurodegenerationinnsfrelateddevelopmentalandepilepticencephalopathy AT yanonaoko involvementofmtorpathwayinneurodegenerationinnsfrelateddevelopmentalandepilepticencephalopathy AT korakengo involvementofmtorpathwayinneurodegenerationinnsfrelateddevelopmentalandepilepticencephalopathy AT yokoyamaatsushi involvementofmtorpathwayinneurodegenerationinnsfrelateddevelopmentalandepilepticencephalopathy AT maizurukanako involvementofmtorpathwayinneurodegenerationinnsfrelateddevelopmentalandepilepticencephalopathy AT kayakitaisei involvementofmtorpathwayinneurodegenerationinnsfrelateddevelopmentalandepilepticencephalopathy AT nishikawakinuko involvementofmtorpathwayinneurodegenerationinnsfrelateddevelopmentalandepilepticencephalopathy AT osawamitsujiro involvementofmtorpathwayinneurodegenerationinnsfrelateddevelopmentalandepilepticencephalopathy AT niwaakira involvementofmtorpathwayinneurodegenerationinnsfrelateddevelopmentalandepilepticencephalopathy AT takenouchitoshiki involvementofmtorpathwayinneurodegenerationinnsfrelateddevelopmentalandepilepticencephalopathy AT hijikataatsushi involvementofmtorpathwayinneurodegenerationinnsfrelateddevelopmentalandepilepticencephalopathy AT shiraitsuyoshi involvementofmtorpathwayinneurodegenerationinnsfrelateddevelopmentalandepilepticencephalopathy AT suzukihisato involvementofmtorpathwayinneurodegenerationinnsfrelateddevelopmentalandepilepticencephalopathy AT kosakikenjiro involvementofmtorpathwayinneurodegenerationinnsfrelateddevelopmentalandepilepticencephalopathy AT saitomegumuk involvementofmtorpathwayinneurodegenerationinnsfrelateddevelopmentalandepilepticencephalopathy AT takitajunko involvementofmtorpathwayinneurodegenerationinnsfrelateddevelopmentalandepilepticencephalopathy AT yoshidatakeshi involvementofmtorpathwayinneurodegenerationinnsfrelateddevelopmentalandepilepticencephalopathy |